How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

44,175 results for

Pacemaker

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer

Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer Electrically stimulated intr Electrically stimulated intra av vesical chemother esical chemotherap apy y for non-muscle-in for non-muscle-invasiv vasive bladder cancer e bladder cancer Interventional procedures guidance Published: 30 January 2019 nice.org.uk/guidance/ipg638 Y Y our responsibility our responsibility This guidance represents the view of NICE, arrived at after careful consideration (...) 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 1 of 41 1 Recommendations Recommendations 1.1 Current evidence on electrically stimulated intravesical chemotherapy for non- muscle-invasive bladder cancer shows there are no major safety concerns. Evidence on efficacy is limited in quantity and quality. Therefore, this procedure should only be used in the context of research. 1.2 Further research should include randomised

2019 National Institute for Health and Clinical Excellence - Interventional Procedures

2. Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults

Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults T T r ranscutaneous neuromuscular electrical anscutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in stimulation for oropharyngeal dysphagia in adults adults Interventional procedures guidance Published: 19 December 2018 nice.org.uk/guidance/ipg634 Y Y our responsibility our responsibility This guidance represents the view of NICE, arrived at after careful consideration (...) 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 1 of 51 1 Recommendations Recommendations 1.1 Current evidence on transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults shows there are no major safety concerns. For adults with dysphagia after a stroke, the evidence on efficacy suggests a potential benefit, but is limited in quality and quantity. Therefore, this procedure should only

2019 National Institute for Health and Clinical Excellence - Interventional Procedures

3. Proposal of a New Electrode and Modality of Electrical Stimulation for Diaphragmatic Pacemakers. Full Text available with Trip Pro

Proposal of a New Electrode and Modality of Electrical Stimulation for Diaphragmatic Pacemakers. This report describes the implantation of a new design of intramuscular electrode to the diaphragm and introduces a new modality of electroventilation for diaphragmatic pacemaker.We used 22 Large White female pigs to test 68 electrodes that were implanted in the abdominal portion of the diaphragm by videolaparoscopy. Animals were submitted to a new protocol of electroventilation with an unpolarized (...) current and a single-channel mode with 1 electrode for each hemidiaphragm during 3 hours.The electrodes were easily fixed to the diaphragm with the help of a deployment device designed for this purpose. There was no evidence of clinical complications such as pneumothorax or bleeding. No significant differences were observed in arterial blood gas analysis and serum lactate levels.The designed electrodes provided an excellent performance in connection between the electrical stimulator and the muscle

2018 Annals of Thoracic Surgery

4. Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews. Full Text available with Trip Pro

Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews. Chronic pain, considered to be pain lasting more than three months, is a common and often difficult to treat condition that can significantly impact upon function and quality of life. Treatment typically includes pharmacological and non-pharmacological approaches. Transcutaneous electrical nerve stimulation (TENS) is an adjunct non-pharmacological treatment commonly recommended by clinicians (...) of TENS; or TENS delivered using different stimulation parameters.Data extraction and analysisTwo authors independently extracted relevant data, assessed review quality using the AMSTAR checklist and applied GRADE judgements where required to individual reviews. Our primary outcomes included pain intensity and nature/incidence of adverse effects; our secondary outcomes included disability, health-related quality of life, analgesic medication use and participant global impression of change.We included

2019 Cochrane

5. Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews. Full Text available with Trip Pro

Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews. Chronic pain, considered to be pain lasting more than three months, is a common and often difficult to treat condition that can significantly impact upon function and quality of life. Treatment typically includes pharmacological and non-pharmacological approaches. Transcutaneous electrical nerve stimulation (TENS) is an adjunct non-pharmacological treatment commonly recommended by clinicians (...) of TENS; or TENS delivered using different stimulation parameters.Data extraction and analysisTwo authors independently extracted relevant data, assessed review quality using the AMSTAR checklist and applied GRADE judgements where required to individual reviews. Our primary outcomes included pain intensity and nature/incidence of adverse effects; our secondary outcomes included disability, health-related quality of life, analgesic medication use and participant global impression of change.We included

2019 Cochrane

6. Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial. Full Text available with Trip Pro

Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial. Permanent artificial pacemaker implantation is a safe and effective treatment for bradycardia and is associated with extended longevity and improved quality of life. However, the most common long-term complication of standard pacemaker therapy is pacemaker-associated heart failure. Pacemaker follow-up is potentially an opportunity to screen for heart (...) failure to assess and optimise patient devices and medical therapy.The study is a multicentre, phase-3 randomised trial. The 1200 participants will be people who have a permanent pacemaker for bradycardia for at least 12 months, randomly assigned to undergo a transthoracic echocardiogram with their pacemaker check, thereby tailoring their management directed by left ventricular function or the pacemaker check alone, continuing with routine follow-up. The primary outcome measure is time to all-cause

2019 BMJ open Controlled trial quality: predicted high

7. The Effectiveness and Risks of Cranial Electrical Stimulation

, cardiac pacemaker, etc.). These subjects’ prior care or usual care was not described. CES was delivered with the Alpha-Stim unit, of which the manufacturer supplied 10 active and 10 inactive units. Subjects used the unit for 60 minutes a day for 5 days. There were no statistically significant differences between groups in the time to sleep, the total time slept, and the number of awakenings per night. 8 Cranial Electrical Stimulation Evidence-based Synthesis Program 15 Summary One very old and one (...) The Effectiveness and Risks of Cranial Electrical Stimulation ? February 2018 Prepared for: Department of Veterans Affairs Veterans Health Administration Quality Enhancement Research Initiative Health Services Research & Development Service Washington, DC 20420 Prepared by: Evidence-based Synthesis Program (ESP) West Los Angeles VA Medical Center Los Angeles, CA Paul G. Shekelle, MD, PhD, Director Department of Veterans Affairs Health Services Research & Development Service Evidence-based

2018 Veterans Affairs Evidence-based Synthesis Program Reports

8. The MicraTM Transcatheter Pacing System, a leadless pacemaker, in patients indicated for single-chamber ventricular pacemaker implantation

About NIPH Close The MicraTM Transcatheter Pacing System, a leadless pacemaker, in patients indicated for single-chamber ventricular pacemaker implantation: A single technology assessment Order Download: Summary Background Permanent cardiac pacing using pacemaker implantation is an effective and necessary treatment for patients suffering from atrial fibrillation and bradycardia. In this single technology assessment, we assessed a leadless pacemaker for patients indicated for single-chamber (...) The MicraTM Transcatheter Pacing System, a leadless pacemaker, in patients indicated for single-chamber ventricular pacemaker implantation The MicraTM Transcatheter Pacing System, a leadless pacemaker, in patients indicated for single-chamber ventricular pacemaker implantation: A single technology assessment - NIPH Search for: Søk Menu To top level Close Infectious diseases & Vaccines Mental & Physical health Environment & Lifestyle Health in Norway Quality & Knowledge Research & Access to data

2018 Norwegian Institute of Public Health

9. Transvenous dual‐chamber pacemaker after paediatric heart transplantation using left ventricle pacing through the coronary sinus Full Text available with Trip Pro

Transvenous dual‐chamber pacemaker after paediatric heart transplantation using left ventricle pacing through the coronary sinus A 12-year-old child with end-stage heart failure due to restrictive cardiomyopathy was submitted to orthotopic heart transplantation. Primary graft dysfunction required venous arterial extra-corporeal membrane oxygenation. Heart function normalized, but complete atrioventricular block remained after 3 weeks. A dual-chamber pacing with transvenous left ventricle (...) pacing through the coronary sinus was performed. At 5-year follow-up, the patient is stable with the same pacing system and with preserved ventricular function.© 2018 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

2018 ESC heart failure

10. Short-term action potential memory and electrical restitution: A cellular computational study on the stability of cardiac repolarization under dynamic pacing. Full Text available with Trip Pro

Short-term action potential memory and electrical restitution: A cellular computational study on the stability of cardiac repolarization under dynamic pacing. Electrical restitution (ER) is a major determinant of repolarization stability and, under fast pacing rate, it reveals memory properties of the cardiac action potential (AP), whose dynamics have never been fully elucidated, nor their ionic mechanisms. Previous studies have looked at ER mainly in terms of changes in AP duration (APD) when (...) on fast pacing rate conditions with a beat-to-beat variable CL, where memory properties emerge from APD vs CL and not from APD vs DI and should thus be stored in APD and not in DI. We provide an ion-currents characterization of such conditions under periodic and random CL variability, and show that the memory stored in APD plays a stabilizing role on AP repolarization under pacing rate perturbations. The gating kinetics of L-type calcium current seems to be the main determinant of this safety

2018 PLoS ONE

11. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Full Text available with Trip Pro

Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Neuropathic pain, which is due to nerve disease or damage, represents a significant burden on people and society. It can be particularly unpleasant and achieving adequate symptom control can be difficult. Non-pharmacological methods of treatment are often employed by people with neuropathic pain and may include transcutaneous electrical nerve stimulation (TENS). This review supersedes one Cochrane Review (...) 'Transcutaneous electrical nerve stimulation (TENS) for chronic pain' (Nnoaham 2014) and one withdrawn protocol 'Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults' (Claydon 2014). This review replaces the original protocol for neuropathic pain that was withdrawn.To determine the analgesic effectiveness of TENS versus placebo (sham) TENS, TENS versus usual care, TENS versus no treatment and TENS in addition to usual care versus usual care alone in the management of neuropathic

2017 Cochrane

12. Neuromuscular electrical stimulation for the prevention of venous thromboembolism. Full Text available with Trip Pro

Neuromuscular electrical stimulation for the prevention of venous thromboembolism. Venous thromboembolism (VTE) is a serious but preventable cause of morbidity and mortality. Neuromuscular electrical stimulation systems (NMES) for the prevention of VTE may be beneficial for patients in whom pharmacological or standard mechanical prophylaxis methods are contraindicated or are regarded as unsafe or impractical. Although findings of experimental studies suggest that NMES reduce venous stasis (...) , the clinical utility and effectiveness of NMES in VTE prevention remain controversial.To assess the effectiveness of neuromuscular electrical stimulation in the prevention of venous thromboembolism.The Cochrane Vascular Group Information Specialist (CIS) searched the Specialised Register (22 March 2017) and the Cochrane Central Register of Controlled Studies (CENTRAL (2017, Issue 2)). The CIS also searched trial registries for details of ongoing and unpublished studies. The review authors searched

2017 Cochrane

13. Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome. Full Text available with Trip Pro

Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome. Patellofemoral pain syndrome, now generally referred to as patellofemoral pain (PFP), is one of the most common orthopaedic disorders, characterised by pain in the anterior or retropatellar knee region. Neuromuscular electrical stimulation (NMES) has been proposed generally as a complementary treatment, associated with other interventions such as exercise, or as a single treatment to increase muscle force, reduce knee (...) pain, and improve function.To assess the effects (benefits and harms) of neuromuscular electrical stimulation for people with patellofemoral pain.We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, PEDro, CINAHL, SPORTDiscus, AMED, LILACS, trial registers, conference abstracts, and reference lists. We carried out the search in May 2017.We included randomised controlled clinical trials

2017 Cochrane

14. Electrical stimulation with non-implanted devices for stress urinary incontinence in women. Full Text available with Trip Pro

Electrical stimulation with non-implanted devices for stress urinary incontinence in women. Several treatment options are available for stress urinary incontinence (SUI), including pelvic floor muscle training (PFMT), drug therapy and surgery. Problems exist such as adherence to PFMT regimens, side effects linked to drug therapy and the risks associated with surgery. We have evaluated an alternative treatment, electrical stimulation (ES) with non-implanted devices, which aims to improve pelvic (...) floor muscle function to reduce involuntary urine loss.To assess the effects of electrical stimulation with non-implanted devices, alone or in combination with other treatment, for managing stress urinary incontinence or stress-predominant mixed urinary incontinence in women. Among the outcomes examined were costs and cost-effectiveness.We searched the Cochrane Incontinence Specialised Register, which contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL

2017 Cochrane

15. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Full Text available with Trip Pro

Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Fibromyalgia is characterised by persistent, widespread pain; sleep problems; and fatigue. Transcutaneous electrical nerve stimulation (TENS) is the delivery of pulsed electrical currents across the intact surface of the skin to stimulate peripheral nerves and is used extensively to manage painful conditions. TENS is inexpensive, safe, and can be self-administered. TENS reduces pain during movement in some people so (...) in adults. We included cross-over and parallel-group trial designs. We included studies that evaluated TENS administered using non-invasive techniques at intensities that produced perceptible TENS sensations during stimulation at either the site of pain or over nerve bundles proximal (or near) to the site of pain. We included TENS administered as a sole treatment or TENS in combination with other treatments, and TENS given as a single treatment or as a course of treatments.Two review authors

2017 Cochrane

16. Transcorneal electrical stimulation for retinitis pigmentosa

Transcorneal electrical stimulation for retinitis pigmentosa 1 Translation of the executive summary of the assessment of potential Transkorneale Elektrostimulation bei Retinopathia Pigmentosa (Version 1.0; Status: 29 August 2014). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Executive Summary IQWiG Reports – Commission No. E14-07 Transcorneal electrical (...) stimulation for retinitis pigmentosa 1 Executive summary of the assessment of potential E14-07 Version 1.0 Transcorneal electrical stimulation for retinitis pigmentosa 29 August 2014 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Transcorneal electrical stimulation for retinitis pigmentosa Commissioning agency: Federal Joint Committee Commission awarded on: 3 July 2014 Internal Commission No.: E14

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

17. Electrical stimulation for pressure injuries: OHTAC recommendation

Electrical stimulation for pressure injuries: OHTAC recommendation Electrical stimulation for pressure injuries: OHTAC recommendation Electrical stimulation for pressure injuries: OHTAC recommendation Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Electrical stimulation for pressure injuries (...) : OHTAC recommendation. Toronto: Health Quality Ontario (HQO). 2017 Authors' conclusions The Ontario Health Technology Advisory Committee recommends against publicly funding electrical stimulation for pressure injuries Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Crush Injuries; Electric Stimulation; Humans Language Published English Country of organisation Canada Province or state Ontario English summary An English language summary is available. Address

2018 Health Technology Assessment (HTA) Database.

18. Electrical stimulation for pressure injuries: a health technology assessment

Electrical stimulation for pressure injuries: a health technology assessment Electrical stimulation for pressure injuries: a health technology assessment Electrical stimulation for pressure injuries: a health technology assessment Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Electrical (...) stimulation for pressure injuries: a health technology assessment. Toronto: Health Quality Ontario (HQO). Ontario health technology assessment series; 17(14). 2017 Authors' conclusions While electrical stimulation is safe to use (GRADE quality of evidence: high) there is uncertainty about whether it improves wound healing (GRADE quality of evidence: low). In Ontario, publicly funding electrical stimulation for pressure injuries could result in extra costs of $0.77 to $3.85 million yearly for the next 5

2018 Health Technology Assessment (HTA) Database.

19. [Transcorneal electrical stimulation for retinitis pigmentosa]

[Transcorneal electrical stimulation for retinitis pigmentosa] Transkorneale elektrostimulation bei retinopathia pigmentosa: potenzialbewertung; auftrag E14-07 [Transcorneal electrical stimulation for retinitis pigmentosa] Transkorneale elektrostimulation bei retinopathia pigmentosa: potenzialbewertung; auftrag E14-07 [Transcorneal electrical stimulation for retinitis pigmentosa] Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Record Status This is a bibliographic record (...) of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Transkorneale elektrostimulation bei retinopathia pigmentosa: potenzialbewertung; auftrag E14-07. [Transcorneal electrical stimulation for retinitis pigmentosa] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 550. 2017 Final

2018 Health Technology Assessment (HTA) Database.

20. [Transcorneal electrical stimulation for retinitis pigmentosa (addendum to commission E14-07)]

[Transcorneal electrical stimulation for retinitis pigmentosa (addendum to commission E14-07)] Transkorneale elektrostimulation bei retinopathia pigmentosa (addendum zum auftrag E14-07); auftrag E14-11 [Transcorneal electrical stimulation for retinitis pigmentosa (addendum to commission E14-07)] Transkorneale elektrostimulation bei retinopathia pigmentosa (addendum zum auftrag E14-07); auftrag E14-11 [Transcorneal electrical stimulation for retinitis pigmentosa (addendum to commission E14-07 (...) )] Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Transkorneale elektrostimulation bei retinopathia pigmentosa (addendum zum auftrag E14-07); auftrag E14-11. [Transcorneal electrical stimulation for retinitis pigmentosa

2018 Health Technology Assessment (HTA) Database.

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>